You got diagnosed. You deserve a next step.

Personalized genetic medicines are an option. Let's find out what's right for you.

Genetic medicine development as a service for rare disease families, foundations, and health systems.

Nome is already trusted by the rare disease community.

5,000+

Patient cases analyzed — and counting
10+

Personalized medicine programs

More than any other company.

— What We Do

We provide genetic medicine development as a service.

Nome is for rare disease families, foundations, and health systems. We are a services company that helps them access and develop personalized genetic medicines. We work across the full lifecycle of a therapeutic program — from treatment design to clinical execution — using an AI platform combined with human experts to make this process faster, lower-cost, and more accessible than traditional drug development. For families and organizations navigating the emerging world of n-of-1 and rare disease genetic therapies, we are the 'easy button' that provides concierge navigation through this process. Nome is the operating system for personalized therapies.™

See how we work

From our founder

The bottleneck isn't science. It's operational complexity.

At 17, Stevie Ringel and his sister were diagnosed with an ultra-rare inherited retinal disease with no approved treatment. That gap is why Nome exists.

Read Our Story

What would have taken us years, they helped us accomplish in months.

Aga Re Rare Disease Parent, VisionBound Foundation

— Shorts

Quick takes from Solving Rare

Watch our founder Stevie Ringel talk with rare disease change-makers about how to truly transform genetic medicine and drive meaningful change for patients.